Evidence map›Paper›PMID 33309601›Full record

ReviewTrends in molecular medicine2021

Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies.

Lena Claesson-Welsh, Elisabetta Dejana, Donald M McDonald

Open access · bronzeAbstract readReview
In one paragraph

Review in Trends in molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 368 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
368citing papers in PubMed, 1 pooled it
26.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

368 citing papers in PubMed, 1 synthesis or guideline pooled it, 585 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Aflibercept and Faricimab Equipotently Restore Endothelial Barrier Function.Investigative ophthalmology & visual science · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Article

308 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Lena Claesson-WelshUppsala University, Rudbeck, SciLifeLab and Beijer Laboratories, Department of Immunology, Genetics and Pathology, Uppsala, Sweden. Electronic address: lena.welsh@igp.uu.se.
Elisabetta DejanaUppsala University, Rudbeck, SciLifeLab and Beijer Laboratories, Department of Immunology, Genetics and Pathology, Uppsala, Sweden; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy.
Donald M McDonaldCardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA. Electronic address: donald.mcdonald@ucsf.edu.
Uppsala University · SEUniversity of California, San Francisco · US

Funding

ENDOTHELIAL PERMEABILITY IN AIRWAY ANGIOGENESISR01HL059157 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCDONALD, DONALD M · 1998 to 2015
$5.5M
Angiopoietin/Tie signaling regulation of vascular leakage in lung inflammationR01HL143896 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCDONALD, DONALD M · 2018 to 2021
$2.5M
Mechanisms, consequences, and reversal of abnormalities in lung lymphaticsR01HL127402 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCDONALD, DONALD M · 2015 to 2018
$2.2M
NHLBI NIH HHS R01 HL059157NHLBI NIH HHS R01 HL127402NHLBI NIH HHS R01 HL143896
6 · The paper itself

Abstract

Leakage from blood vessels into tissues is governed by mechanisms that control endothelial barrier function to maintain homeostasis. Dysregulated endothelial permeability contributes to many conditions and can influence disease morbidity and treatment. Diverse approaches used to study endothelial permeability have yielded a wealth of valuable insights. Yet, ongoing questions, technical challenges, and unresolved controversies relating to the mechanisms and relative contributions of barrier regulation, transendothelial sieving, and transport of fluid, solutes, and particulates complicate interpretations in the context of vascular physiology and pathophysiology. Here, we describe recent in vivo findings and other advances in understanding endothelial barrier function with the goal of identifying and reconciling controversies over cellular and molecular processes that regulate the vascular barrier in health and disease.

Indexed as

AnimalsCapillary PermeabilityEndothelial CellsEndothelial Growth FactorsEndothelium, VascularHumansIntercellular JunctionsReceptors, OpioidReceptors, Vascular Endothelial Growth Factorrho GTP-Binding ProteinsSignal TransductionVascular Endothelial Growth Factor AEndothelial Growth FactorsG protein-coupled receptor C3Receptors, OpioidReceptors, Vascular Endothelial Growth Factorrho GTP-Binding ProteinsVascular Endothelial Growth Factor Aendothelial barrier functionendothelial cell junctionsgap formationG protein-coupled receptorspostcapillary venulesRho GTPasesVEGF receptors

Identifiers

PMID33309601
PMCPMC8005435
OpenAlexW3111954174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.